1. Home
  2. KALV vs FUFU Comparison

KALV vs FUFU Comparison

Compare KALV & FUFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • FUFU
  • Stock Information
  • Founded
  • KALV N/A
  • FUFU 2020
  • Country
  • KALV United States
  • FUFU Singapore
  • Employees
  • KALV N/A
  • FUFU N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • FUFU
  • Sector
  • KALV Health Care
  • FUFU
  • Exchange
  • KALV Nasdaq
  • FUFU NYSE
  • Market Cap
  • KALV 642.3M
  • FUFU 576.7M
  • IPO Year
  • KALV N/A
  • FUFU N/A
  • Fundamental
  • Price
  • KALV $11.49
  • FUFU $3.20
  • Analyst Decision
  • KALV Strong Buy
  • FUFU Buy
  • Analyst Count
  • KALV 8
  • FUFU 2
  • Target Price
  • KALV $24.83
  • FUFU $6.25
  • AVG Volume (30 Days)
  • KALV 1.1M
  • FUFU 508.6K
  • Earning Date
  • KALV 07-10-2025
  • FUFU 06-05-2025
  • Dividend Yield
  • KALV N/A
  • FUFU N/A
  • EPS Growth
  • KALV N/A
  • FUFU N/A
  • EPS
  • KALV N/A
  • FUFU 0.01
  • Revenue
  • KALV N/A
  • FUFU $396,963,000.00
  • Revenue This Year
  • KALV N/A
  • FUFU $4.17
  • Revenue Next Year
  • KALV N/A
  • FUFU $59.54
  • P/E Ratio
  • KALV N/A
  • FUFU $282.79
  • Revenue Growth
  • KALV N/A
  • FUFU 7.13
  • 52 Week Low
  • KALV $7.30
  • FUFU $2.91
  • 52 Week High
  • KALV $15.50
  • FUFU $6.33
  • Technical
  • Relative Strength Index (RSI)
  • KALV 35.75
  • FUFU 44.05
  • Support Level
  • KALV $11.10
  • FUFU $2.96
  • Resistance Level
  • KALV $12.17
  • FUFU $3.38
  • Average True Range (ATR)
  • KALV 0.86
  • FUFU 0.24
  • MACD
  • KALV -0.21
  • FUFU 0.02
  • Stochastic Oscillator
  • KALV 30.34
  • FUFU 43.75

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About FUFU BITFUFU INC

BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets. The company generates the majority of its revenue from the sale of cloud-mining solutions, followed by Self-mining revenue. Geographically, the company generates revenue from North America, Asia, Europe, and Others.

Share on Social Networks: